Confusion in cancer patients: a rational clinical approach
Lechaschi Vrach · 29.10.2026 · (10(29))
DOI: 10.51793/os.2026.29.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lechaschi Vrach, erschienen am 29.10.2026. Verfasst von E.S. Vvedenskaya und 1 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Along with the rising cancer incidence there has also been a rapid expansion of new cancer treatments, such as immune checkpoint inhibitors, T-cell therapy, antiangiogenic therapy, and various targeted agents, many of which frequently cause neurological complications, including confusion. Confusion is common in cancer patients and is a cause of health status deterioration, higher mortality, and prolonged hospital stays, including intensive care units and also negatively impacts on mental state of both patients and their families.
Objective
The purpose of this review is to present a practical clinical approach to identifying and differentially diagnosing varying degrees of confusion in cancer patients to facilitate timely care.
Results
The differential diagnosis of confusion in cancer patients is broader than in any other patient profile. Physicians must differentiate between common conditions that lead to the development of confusion and also consider causes specific to this patient population, including complications associated with both cancer itself and anticancer treatment and the use of neurotoxic drugs. Neurological examination may reveal focal abnormalities suggestive of brain metastases, signs of increased intracranial pressure such as optic nerve edema, abducens nerve palsy suggestive of leptomeningeal metastases, or stunning as a result of global hypoxic or metabolic encephalopathy. A comprehensive laboratory evaluation is necessary to identify metabolic and immune abnormalities common in cancer patients, including tumor lysis syndrome, malignant hypercalcemia, cachexia/anorexia, and paraneoplastic autoimmune syndromes. With a rational clinical approach confusion is reversible in approximately 50% of cancer patients. Early detection and treatment of this condition are critical to improving clinical outcomes.
Zitieren
APA
Vvedenskaya, E., & Kuchina, V. (2026). Confusion in cancer patients: a rational clinical approach. Lechaschi Vrach. https://doi.org/10.51793/os.2026.29.10.005
Vancouver
Vvedenskaya E, Kuchina V. Confusion in cancer patients: a rational clinical approach. Lechaschi Vrach. 2026. doi:10.51793/os.2026.29.10.005
BibTeX
@article{Vvedenskaya2026,
author = {Vvedenskaya, E.S. and Kuchina, V.S.},
title = {Confusion in cancer patients: a rational clinical approach},
journal = {Lechaschi Vrach},
year = {2026},
number = {10(29)},
doi = {10.51793/os.2026.29.10.005}
}
EUVIMED